Categories: News

Phemex Launches 30,000 USDT Incentive Program for LIT and MAGMA Trading Pairs

APIA, Samoa, Dec. 31, 2025 /PRNewswire/ — Phemex, a user-first crypto exchange, has introduced a structured reward initiative for the newly listed LIT and MAGMA trading pairs. Running from December 31, 2025, to January 7, 2026, the program features a total allocation of 30,000 USDT designed to support liquidity and market engagement within its derivatives ecosystem.

- Advertisement -

The initiative highlights two infrastructure approaches in the DeFi sector. Lighter (LIT) is an order-book DEX infrastructure focused on institutional-grade capital efficiency and low-latency execution. Magma Finance (MAGMA) is an AMM DEX built for MOVE-based blockchains, utilizing a liquidity incentive engine designed to align the interests of traders, governance participants, and liquidity providers.

- Advertisement -

To ensure balanced participation, Phemex has partitioned the 30,000 USDT allocation into two categories:

- Advertisement -

Reward Mechanism Details:

- Advertisement -
  • Engagement-Based Pool (10,000 USDT): Dedicated to general interaction tasks, including social referrals and daily trading milestones. This pool is intended to broaden the user base for these emerging protocols.
  • Volume-Driven Competition (20,000 USDT): A competitive track focused on futures trading volume for LIT and MAGMA. Rewards are distributed based on ranking performance, with the top three participants eligible for a significant portion of the pool, including a maximum individual reward of 4,000 USDT.

By integrating these specialized protocols, Phemex continues to diversify its high-performance trading environment, providing users with exposure to the latest developments in order-book and MOVE-based AMM technologies.

- Advertisement -

About Phemex
Founded in 2019, Phemex is a user-first crypto exchange trusted by over 10 million traders worldwide. The platform offers spot and derivatives trading, copy trading, and wealth management products designed to prioritize user experience, transparency, and innovation. With a forward-thinking approach and a commitment to user empowerment, Phemex delivers reliable tools, inclusive access, and evolving opportunities for traders at every level to grow and succeed.

- Advertisement -

For more information, please visit: https://phemex.com/ 

- Advertisement -

Photo – https://mma.prnewswire.com/media/2853279/Phemex_Launches_30_000_USDT_Incentive_Program_LIT_MAGMA_Trading.jpg
Logo – https://mma.prnewswire.com/media/2819516/Phemex_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/phemex-launches-30-000-usdt-incentive-program-for-lit-and-magma-trading-pairs-302651201.html

- Advertisement -

Recent Posts

Axi Launches “The Strategy Room” Podcast Hosted by Kathy Lien

New Axi Select series features traders and market professionals discussing strategy, risk management, and global…

30 minutes ago

NYSE Content Update: Michael + Susan Dell to Ring Opening Bell with Invest America

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, March 25, 2026…

30 minutes ago

Bitmine Immersion Technologies (BMNR) Announces Launch of MAVAN (Made In America VAlidator Network), the Company’s Proprietary Staking Solution

MAVAN will be the largest Ethereum staking service provider globally and will provide staking services…

30 minutes ago

Manchester United and Moroccan International Noussair Mazraoui becomes strategic partner with the world’s leading Islamic Fintech, Wahed

LONDON, March 25, 2026 /PRNewswire/ -- Wahed, the world's leading Islamic fintech welcomes Noussair Mazraoui…

30 minutes ago

SANY Debuts World’s First Intelligent Hybrid Pump Truck

SHANGHAI, March 25, 2026 /PRNewswire/ -- SANY recently held a product launch event themed "Usher…

30 minutes ago

Bioptimus Announces STELA: The World’s Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

The global initiative aims to profile up to 100,000 patient specimens to scale M-Optimus, the…

3 hours ago